Clinician Information
In the ‘pre-prophylaxis era’, approximately 8% of kidney transplant recipients experienced symptomatic CMV infection. In patients receiving prophylaxis, 1 year incidence of CMV disease is reported to be 19.2%, in D+ / R- group and 2.5% in D- / R- group.
Being updated
Being updated
Being updated
Being updated
Being updated